Ocean Biomedical ( (OCEA) ) has released a notification of late filing.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Ocean Biomedical, Inc. has announced a delay in filing its Form 10-K (Yearly Report) for the financial period ending December 31, 2024. The delay is primarily due to the late receipt of essential information from third parties, which is necessary for the auditors to complete their procedures. The company expects to file the report by the end of the week, well within the SEC’s allowable extension period. Ocean Biomedical does not anticipate any significant changes in its financial results from the previous fiscal year. The company remains committed to compliance, with the notification signed by Chief Financial Officer Jolie Kahn.
More about Ocean Biomedical
YTD Price Performance: -90.85%
Average Trading Volume: 54,951,067
Technical Sentiment Signal: Buy
Current Market Cap: $7.59M
For an in-depth examination of OCEA stock, go to TipRanks’ Stock Analysis page.